What is Babyscripts?
Babyscripts was founded six years ago to rethink the delivery of pregnancy care through the power of technology and remote patient monitoring and address the critical shortage of obstetrical providers in the U.S. Babyscripts offers comprehensive virtual maternity care which, through managing various levels of risk, addresses an outdated model for pregnancy care that has not moved the needle in decreasing maternal morbidity and mortality; an inability to address social determinants of health; and now the critical need to transition care outside of the clinic due to Covid-19. The company’s solution for virtual maternity care manages the various risk-levels of a maternal health population to address some of the largest drivers of costs and complications in perinatal care.
Babyscripts Board of Directors
Mr. Winder co-leads the investment activities of the MemorialCare Innovation Fund (MCIF), the strategic corporate venture capital fund affiliated with the MemorialCare Health System in southern California. He has over 20 years of venture capital investment experience in early to mid-stage healthcare technology companies. He sources, leads, and syndicates deals, and subsequently, he works closely with portfolio companies to develop scalable commercial and marketing strategies to maximize value for founders and shareholders.
Mr. Winder has both private and public company board experience and is currently (or formerly) a Board Director or Observer in a broad spectrum of companies in the Digital Health, Healthcare IT, Medical Device, Diagnostics and Life Sciences companies including Aileron Therapeutics (IPO), AristaMD, Aventura (acquired by Philips Medical), Ayogo Health, BabyScripts, ClearDATA, Cleveland HeartLab (acquired by Quest Diagnostics), Foldax, InfoBionic, Laudio, Molecular Templates (IPO), Oculus Health, Protenus, ShapeUp (merged with Virgin Pulse, acquired by Marlin), Silvercloud Health (acquired by Amwell), Saladax Biomedical, Twistle (acquired by Health Catalyst), MedVentive (acquired by McKesson), Qstream, WellDoc, and Xcellerex (acquired by GE Healthcare).
Prior to joining MCIF, Mr. Winder was Co-Founder (and remains) Managing Director at Excel Venture Management, and independent venture capital firm focused on Healthcare and Life Sciences. Prior to Excel Venture, Mr. Winder was a Principal at Biotechonomy Ventures where he was involved in the founding of Synthetic Genomics, the firm’s investments in BioTrove (acquired by Life Technologies), BIOCIUS (acquired by Agilent Technologies), and Xcellerex (acquired by GE Healthcare).
Early in his career, Mr. Winder was an award-winning sales and marketing executive at medical equipment and diagnostics companies, Midmark Corporation and MGC Diagnostics. He graduated magna cum laude with an MBA from Olin Graduate School of Business at Babson College, where he was a Fellow in the Center for Technology Enterprise. He earned a BA in Biology and a minor in Economics from Colby College.
Matt is a Principal at Cigna Ventures, the strategic venture fund of Cigna Corp., where he leads investment activities. He has over 10 years of healthcare experience investing in early-stage companies and organizing value-based partnerships. He currently serves as a board member or observer at Datavant, Babyscripts, and Flume Health.
Matt earned a bachelor’s degree from Brigham Young University and an MBA from UNC Kenan-Flagler. He currently lives in Salt Lake City with his wife and four children where he loves to golf, ski, and trail run.
Katerina leads venture investment activity and portfolio management for Philips Ventures in North America, the strategic venture capital arm of Philips. She is based in Boston, MA and is focused on early commercial stage digital health investment opportunities that align with Philips’s strategy to improve people's health and well-being through meaningful innovation.
Katerina has 20+ year global experience in Finance, M&A, Venture Capital in technology and digital health sectors, holds MBA from MIT, and is ACCA certified chartered accountant.
She is a Board Director or Board Observer at several startups including MOVN Health, Orbita, PreciseDx, Carevive, Babyscripts. She is also a Founding partner at OKM Capital. Mentor and judge at MassChallenge startup accelerator. Board Advisor at BHS Innovation Fund. Organizing Committee Member for the MIT Sloan CFO Summit. Member CFO Leadership Council. Member Financial Executives International (FEI). Ambassador for the AI Innovators Community.
Linda Elam is a health policy and management leader with deep expertise in the financing and delivery of health care to vulnerable populations, and broad experience across academic, philanthropic, federal and state government, and private sectors. Presently, Dr. Elam is a Managing Director at Manatt Health, where she focuses on issues relating to health equity, Medicaid policy, life sciences and health strategy. Prior to joining Manatt, Dr. Elam was CEO and Plan President of Amerigroup, District of Columbia, Inc., a managed care organization serving the Medicaid population in Washington, D.C.
Previously, Dr. Elam served as the deputy assistant secretary for planning and evaluation directing the office of Disability, Aging and Long-Term Care Policy at the US Department of Health and Human Services. Dr. Elam provided leadership on policies supporting the independence, health and productivity of elderly individuals and people with physical and mental disabilities.
At the state level, Dr. Elam was senior deputy director and State Medicaid Director at the District of Columbia’s Department of Health Care Finance (DHCF). As Medicaid director, she oversaw the offices responsible for program operations, policy and research, health care delivery management, health reform and innovation, long term care, and the Office of the Medical Director.
Prior to her government service, Dr. Elam was a principal policy analyst with the Henry J. Kaiser Family Foundation, where she focused on prescription drug policy, Medicaid and access to care, and racial and ethnic disparities in health care. She has authored and contributed to briefs, journal articles and book chapters, primarily in the area of prescription drug policy for low-income Americans. She has served as a professorial lecturer at the Milken Institute School of Public Health at George Washington University, and she serves on several boards and commissions, including the Board of Trustees of Altarum, Inc.; the National Advisory Board of the Institute for Healthcare Policy Innovation at the University of Michigan; the Executive Committee of the Stakeholder Engagement Team of the National Institute on Aging IMPACT Collaboratory; and the District of Columbia Commission on Health Equity. Dr. Elam received her B.S. in zoology with honors from Howard University, her M.P.H. in Health Policy and Administration from the University of California at Berkeley, and her Ph.D. in Health Policy and Management from the Johns Hopkins University School of Public Health.
Until December 2017, Ms. Schweitzer was the CEO PatientMatters, LLC. Century Capital and Ms. Schweitzer formed PatientMatters in 2012. PatientMatters is a purpose-built Healthcare Receivable company designed to enhance the patient’s experience while improving patient receivable performance for providers. PatientMatters was acquired by First Source in December 2019.
Ms. Schweitzer has focused on the revenue cycle management industry for the past 30+ years. In such capacity, Ms. Schweitzer has held numerous founder and executive/industry association leadership roles. Ms. Schweitzer joined Caremedic in March of 2003 as COO and was appointed Chairman of the Board and CEO in September 2003. Under her leadership, Caremedic achieved a lead position in the HCIT revenue cycle market. During her tenure, revenue and EBITDA grew by 650 percent and Caremedic successfully brought to market the first enterprise class revenue management system, the Electronic Financial Record (eFR). Ms. Schweitzer sold Caremedic to Optum in December 2019.
Ms. Schweitzer also served in a consulting capacity for MedUnite Inc., a consortium of seven health plans, and was CEO of Presideo, Inc., which developed and marketed a biometric security technology for HCIT systems. Presideo was later sold to Smart Biometrics, Inc. She was also Sr VP of Operations with ENVOY Corporation (now Change Healthcare), the nation’s largest healthcare transactions company.
Ms Schweitzer, in 2017 along with three partners founded Blue Ox Healthcare Partners. Blue Ox is a private equity firm focused on healthcare. The firm seeks to invest in commercial growth stage life sciences companies in the middle market. Ms. Schweitzer left Blue Ox to work in her field of expertise. Ms. Schweitzer now serves as an Executive Advisor to HLM Venture Partners.
In addition to her executive positions, Ms. Schweitzer served on the Advisory Board of NDCHealth and as a consultant to Wellpoint Health Networks,Inc. , Aetna Insurance, the National Blue Cross Blue Shield Association, among others.
Mr. Heise leads the investing activities of MemorialCare investment fund. Over the last 30+ years, Mr. Heise has accumulated a broad range and scope of healthcare experience within both the non-profit and for-profit arenas. His accomplishments include business development and operating experience in the entrepreneurial start-up companies, physician organizations, community hospitals and academic medical centers.
Mr. Heise’s experience also includes participation on the Board of Directors for several privately held, venture capital funded companies, including Accenx Technologies (acquired by Initiate Systems), Arista MD, Ascender Software (acquired by Matrix Medical Network), Aventura (acquired by Phillips), Care Team Connect (acquired by The Advisory Board Company), Foldax, Healthcare Dataworks (acquired by Health Catalyst), MD Insider (acquired by Accolade), PerfectServe (acquired by K-1 Investment Management), Phynd (acquired by Symplr), Prescient Surgical, Radianse (acquired by BL Technologies), Silversheet (acquired by AMN Healthcare), ThromboVision, Twistle (acquired by Health Catalyst) and Wellist. In addition, Mr. has currently (or formerly) holds board observer rights with Advanced Practice Strategies (acquired by Relias Learning), BabyScripts, ForHealth Technologies (acquired by Baxa Corporation, Gauss Surgical (acquired by Stryker), Hyp3r, Ivantis (acquired by Alcon), MedVentive (acquired by McKesson), MindFrame (acquired by Covidien), SilverCloud (acquired by AmericanWell) and Skylight Healthcare Systems (acquired by GetWell Network).
In addition to his role at MemorialCare Innovation Fund, Mr. Heise is also senior managing Director at Summation Health Ventures and Vice President at National Healthcare Services. Prior to those rolls, Mr. has held several operational rolls with several start-up companies and was clinical administrator at Los Angeles County and University of Southern California Medical Center.
Mr. Heise earned a Masters of Healthcare Service Administration from the University of Michigan, as well as a Bachelor of Arts in Psychology from Grinnell College.
Steve is a General Partner at the CU Healthcare Innovation Fund, an early stage venture fund focused in both digital health and therapeutics, affiliated with the University of Colorado Anschutz Medical Campus in Denver, CO. He is also an angel investor in dozens of early stage digital health ventures.
Steve was on the Innovation Advisory Board at the Cleveland Clinic for over 15 years, and serves as an Entrepreneur in Residence at Mass General Brigham Health in Boston.
Steve has also co-founded several companies including Axentis, a SaaS-based pharma and enterprise software company (sold to Wolters Kluwer); Complient, an Internet-based BPO service company that improves the efficacy of emergency medical response (sold to Cardiac Science); Thermoscan™, maker of the Thermoscan Instant Thermometer (sold to Gillette); and Dental Research Corp., maker of the Interplak™ electric toothbrush (sold to Bausch & Lomb). In many cases Steve served as CEO or in other key roles during growth stages.
Steve has raised over $300 million from venture and corporate capital sources for the companies he has founded and co-founded.
He currently serves as either a board member or observer at ClinOne, RxREVU, Riva Health, AristaMD, Carta Healthcare, Reimagine Care, Cured, Babyscripts, GoCheck Kids, and was a founding investor and on the board of Explorys, a pioneer in the healthcare big data analytics space sold to IBM, and Conversa Health, recently sold to Amwell.
Steve is an advisor to many companies including Fitzroy health, Firefly Health, Torq Interface, OMNY, Vectorcare and 149 Medical.
Steve plays the bluegrass banjo, is a telemark skier, cycles, has four grown children and lives in Crested Butte Colorado.
Dr. Enrique Segura currently serves as a chairman of the board of ENSE Group, a holding company in Washington, DC, U.S.A. with revenues of 3 billion dollars and operations in more than 45 countries worldwide. Dr. Segura serves in executive leadership positions in all four companies within ENSE Group. He is President of Alex Stewart International LLC, a company specializing in the auditing of mining and petroleum concerns on behalf of governments; as CEO of Securiport LLC, a firm providing intelligent immigration security systems; and as Director of both Harbass LLC, which specializes in advising foreign governments on foreign debt renegotiation and debt management.
Previous to these positions, Dr. Segura served as Chief Executive Officer of SWIPCO U.S.A., a firm providing procurement services to governments in 17 countries; as Chief Executive Officer of Pricesaroundtheworld.com, an internet company providing comparative price information for marketing and customer service purposes; and as President of Inspection and Control Services, Ltd. (ICS), a company providing pricing information to customs services for the assessment of duties on imported goods. Dr. Segura’s diplomatic assignments include serving as Honorary Consul of the Republic of Uganda in Argentina since 1996, and as President’s Envoy for the Government of Gabon. He is Vice Chairman of the Board of Trustees of the Catholic University of America and a member of the Board of Directors of both Catholic Charities of Washington and Trust for the Americas of the Organization of American States. Dr. Segura received his B.A. in Accounting from Cuyo National University, Mendoza, Argentina; his M.B.A. and Ph.D. from Autónoma University, Madrid; and is an OPM Graduate of Harvard University, Boston, U.S.A.
Former Director, ONC
President Emeritus, ACOG
Partner, Sirona Strategies
Committed to Changing Maternal Healthcare
Babyscripts is continuing to make rigorous investments in the Medicaid space and advocating for maternal healthcare mandates at the state and federal levels. We’ve worked and continue to advocate to open up pathways to reimbursement and access so that delivering the best in maternal healthcare never has to be a choice or come at a cost to the mother.
Want to join the team?
Babyscripts is a fast-paced, fully remote, femtech company committed to changing the maternal healthcare landscape with digital technology to support moms during pregnancy and postpartum. Check out our career opportunities